STRatifying Adult DIffuse Lower-grade Gliomas Based on Their VARIed Metabolic Profiles (STRADIVARI Project)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

About this trial

The goal of this observational study is to better characterise lower-grade gliomas from a molecular and metabolic point of view, so to identify further subgroups of these tumours with different behaviour and, possibly, different treatment susceptibility.

Participants of prospective metabolic cohort will be subjected to routine treatment, part of the exceeding tutor material will be subjected to advanced molecular-metabolic analyses to desume their metabolic profile to be then correlated with clinical outcome (progression-free survival, overall survival, response to therapy/progression) and diagnosis (astrocytoma/oligodendroglioma and grade).

Critical enzymes identified from metabolic analyses on the first cohort will be tested on a protein level on a retrospective cohort of patients previously operated and for whom fully available clinical history and pathological material is available in Institutional archive (no need for further intervention on these patients) to see if they actually correlate with clinical outcome.

Eligibility criteria

Qualifiers

Radiological diagnosis of brain tumor compatible with lower grade glioma

Full clinical history

Disqualifiers

Current pregnancy or lactation

Patients not able to provide informed consent

Confirmed diagnosis of lower grade glioma

Full clinical and radiological history

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

110 Participants
are grouped into 2 trial groups

Sponsors and collaborators

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Lead sponsor

Università Vita-Salute San Raffaele

Collaborator

University of Bari

Collaborator

Ospedale San Paolo Bari

Collaborator